Premium
Hepatic miR‐33a/miR‐144 and their target gene ABCA1 are associated with steatohepatitis in morbidly obese subjects
Author(s) -
VegaBadillo Joel,
GutiérrezVidal Roxana,
HernándezPérez Hugo A.,
VillamilRamírez Hugo,
LeónMimila Paola,
SánchezMuñoz Fausto,
MoránRamos Sofía,
LarrietaCarrasco Elena,
FernándezSilva Itzel,
MéndezSánchez Nahúm,
Tovar Armando R.,
CamposPérez Francisco,
VillarrealMolina Teresa,
HernándezPando Rogelio,
AguilarSalinas Carlos A.,
CanizalesQuinteros Samuel
Publication year - 2016
Publication title -
liver international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.873
H-Index - 110
eISSN - 1478-3231
pISSN - 1478-3223
DOI - 10.1111/liv.13109
Subject(s) - steatohepatitis , abca1 , fatty liver , medicine , abcg1 , endocrinology , liver x receptor , cholesterol , biology , gene , disease , biochemistry , transporter , nuclear receptor , transcription factor
Background and Aim Abnormal cholesterol metabolism may contribute to the pathogenesis of non‐alcoholic steatohepatitis (NASH) and fibrosis. miR‐33 and miR‐144 regulate adenosine triphosphate binding cassette transporter ( ABCA1) and other target genes involved in cholesterol efflux, fatty acid oxidation and inflammation. We explored relationships between non‐alcoholic fatty liver disease (NAFLD) and the hepatic expression of ABCA1/ABCG1, as well as other target genes regulated by miR‐33 (carnitine O‐octanoyltransferase, CROT and hydroxyacyl‐CoA‐dehydrogenase β‐subunit, HADHB ) and miR‐144 (toll‐like receptor‐2, TLR2 ). Moreover, we evaluated whether the expression of these genes is correlated with miR‐33a/b and miR‐144 expression in Mexican individuals with morbid obesity. Methods Eighty‐four morbidly obese subjects undergoing bariatric surgery were included in this study. Liver biopsies were obtained to measure hepatic triglyceride and free cholesterol contents, as well as ABCA1, ABCG1, CROT, HADHB, TLR2, miR‐33a/b and miR‐144 expression. Results Hepatic free cholesterol content was significantly increased in NASH as compared to non‐NASH subjects, while ABCA1 and ABCG1 protein levels significantly decreased with NASH and fibrosis progression. The relative expression of miR‐33a and miR‐144 correlated inversely with ABCA1 but not with ABCG1 protein levels. Moreover, both miRNAs increased significantly in NASH individuals. miR‐33 target genes CROT and HADHB correlated inversely with miR‐33a. However, the expression of these genes was not associated with NASH. Conclusions miR‐33a/144 and their target gene ABCA1 may contribute to the pathogenesis of NASH in morbidly obese subjects.